Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

National Statistical Service of the Republic of Armenia

Nom variantlari: ARMSTAT · NSS

Davlat:
AM
ROR:
https://ror.org/037g7hc89
1
h-indeks
7
Iqtiboslar
24
Asarlar
17
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
013450120162017201820192021202220232024202520262016: Nashrlar 0, Iqtiboslar 12017: Nashrlar 1, Iqtiboslar 02018: Nashrlar 3, Iqtiboslar 12019: Nashrlar 1, Iqtiboslar 02021: Nashrlar 0, Iqtiboslar 12022: Nashrlar 4, Iqtiboslar 02023: Nashrlar 3, Iqtiboslar 02024: Nashrlar 2, Iqtiboslar 02025: Nashrlar 2, Iqtiboslar 02026: Nashrlar 1, Iqtiboslar 1

Iqtibos tarixi

0120162017201820192021202220232024202520262016: Iqtiboslar 12017: Iqtiboslar 02018: Iqtiboslar 12019: Iqtiboslar 02021: Iqtiboslar 12022: Iqtiboslar 02023: Iqtiboslar 02024: Iqtiboslar 02025: Iqtiboslar 02026: Iqtiboslar 1

Nashr tarixi

0134520162017201820192021202220232024202520262016: Nashrlar 02017: Nashrlar 12018: Nashrlar 32019: Nashrlar 12021: Nashrlar 02022: Nashrlar 42023: Nashrlar 32024: Nashrlar 22025: Nashrlar 22026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0120162017201820192021202220232024202520262016: h-indeks 12017: h-indeks 12018: h-indeks 12019: h-indeks 12021: h-indeks 12022: h-indeks 12023: h-indeks 12024: h-indeks 12025: h-indeks 12026: h-indeks 1

Eng koʻp iqtibos qilingan asarlar

  1. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?20151 iqtibos
  2. Rotavirus Vaccine Effectiveness Stratified By National-Level Characteristics: An Introduction to the 24-Country MNSSTER-V Project, 2007–202320241 iqtibos
  3. Ahmet Dursun Natıki ve Divanı Üzerine20020 iqtibos
  4. Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)20130 iqtibos
  5. A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients20130 iqtibos
  6. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study20150 iqtibos
  7. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?20150 iqtibos
  8. State regulation in the area оf supports of use of renewable power sources20170 iqtibos
  9. HIV care in Central and Eastern Europe: How close are we to the target?20180 iqtibos
  10. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study20180 iqtibos